2/6/2013

Novozymes expects to increase sales and efficiency through the purchase of Bio-Products, a unit of Iogen that was auctioned off. "We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes," Novozyme executive Andrew Fordyce said.

Full Story:
Bloomberg

Related Summaries